Jpmorgan Chase & CO Fulgent Genetics, Inc. Put Options Transaction History
Jpmorgan Chase & CO
- $1.14 Trillion
- Q2 2024
Put Options
0 transactions
| Quarter | Operation | Price Per put | puts change | puts Held | SEC Form |
|---|
Others Institutions Holding FLGT
# of Institutions
193Shares Held
15.3MCall Options Held
1.07MPut Options Held
27.9K-
Black Rock Inc. New York, NY3.92MShares$84.5 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.44MShares$30.9 Million0.0% of portfolio
-
Dimensional Fund Advisors LP Austin, TX1.22MShares$26.2 Million0.01% of portfolio
-
Israel Englander Millennium Management LLC | New York, Ny959KShares$20.7 Million0.01% of portfolio
-
Park West Asset Management LLC Larkspur, CA833KShares$18 Million1.3% of portfolio
About Fulgent Genetics, Inc.
- Ticker FLGT
- Exchange NASDAQ
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 30,265,800
- Market Cap $653M
- Description
- Fulgent Genetics, Inc., together with its subsidiaries, provides COVID-19, molecular diagnostic, and genetic testing services to physicians and patients in the United States and internationally. The company offers genetic tests comprising Focus and Comprehensive oncology panels tests; Beacon carrier screening panels test for inherited conditions...